Deep Brain Stimulation for Obesity in Patients With Prader-Willi Syndrome
This study of a case series of 4 patients investigates the safety and efficacy of deep brain stimulation for obesity associated with Prader-Willi syndrome.
Related Articles
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies
This review examines the epidemiology, transmission, clinical presentation, assessment and diagnosis, prognosis, management and treatment, and prevention of mpox.
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients
This cohort study assesses the risk of development of type 2 diabetes in pediatric patients aged 10 to 19 years after receiving a COVID-19 diagnosis…
Race and Ethnicity and Clinician Linguistic Expressions of Doubt in Admission Notes
This cohort study investigates the association of patient race and ethnicity with clinician expressions of doubt in hospital admission notes.
Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists
This cohort study uses a propensity score–matched analysis to assess suicidal ideation or attempts following exposure to glucagon-like peptide 1 receptor agonists (GLP1R) in adolescents…
Skin Biopsies vs CSF in the Diagnosis of Prion Diseases
This diagnostic study evaluates the ability of multiple skin biopsies to detect prion seeding activity compared with the cerebrospinal fluid (CSF) as a diagnostic biomarker…
Preexposure Prophylaxis (PrEP) for HIV
This JAMA Insights discusses the expanding PrEP options for preventing HIV, including the considerations for initiation and follow-up and implementation challenges of these medications.
Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk
This multicenter randomized clinical trial investigates the efficacy and safety of acupuncture compared with sham acupuncture in patients with chronic sciatica from herniated disk.
The US FDA’s New Rule for Regulating Laboratory-Developed Tests
This Viewpoint discusses potential benefits and obstacles regarding US Food and Drug Administration (FDA) oversight of laboratory-developed tests.
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients
This cohort study assesses the risk of development of type 2 diabetes in pediatric patients aged 10 to 19 years after receiving a COVID-19 diagnosis…
Use of Recalled Devices in FDA New Device Authorizations and Risk of Subsequent Recalls
This cross-sectional study evaluates the frequency of new devices receiving US Food and Drug Administration approval through its 510(k) pathway based on predicate devices that…
